In the first year after diagnosis, when melanoma cancer patients have more frequent visits to the doctors and are more likely to undergo additional medical examinations including PSA testing, prostate cancer risk was only slightly insignificantly elevated. This evidence concerns the gene KLK3 and prostate cancer.